Item 5.07. Submission of Matters to a Vote of Security Holders
Following the Annual Meeting of the Stockholders ofNatus Medical Incorporated (the "Company") onJune 17, 2020 (the "Annual Meeting"), Broadridge, the independent inspector of elections for the Annual Meeting, delivered its final vote tabulation onJune 17, 2020 that certified the voting results for each of the matters set forth below that were submitted to a vote at the Annual Meeting. As of the close of business onApril 24, 2020 , the record date for the Annual Meeting, 33,802,362 shares of the Company's common stock ("Common Stock"), were outstanding and entitled to vote. 31,526,306 shares of Common Stock were voted in person or by proxy at the Annual Meeting, representing 93.26% of the shares entitled to be voted.
The final voting results for the Annual Meeting are as follows:
Proposal 1: Election of the following directors:
Nominee For Against Abstain Broker Non-Votes Jonathan A. Kennedy 28,282,076 843,639 102,999 2,245,269 Barbara R. Paul 28,240,674 967,569 20,471 2,245,269 Alice D. Schroeder 27,379,146 1,829,097 20,471 2,245,269 Thomas J. Sullivan 27,826,485 1,297,238 104,991 2,245,269 Ilan Daskal 28,341,224 783,468 104,022 2,245,269 Proposal 2: Advisory vote to approve the Company's Named Executive Officer compensation. For Against Abstain Broker Non-Votes 27,252,778 1,938,241 37,695 2,245,269
Proposal 3: Ratification of the appointment of
For Against Abstain Broker Non-Votes 31,394,776 46,207 33,000 -
No other matters were considered or voted upon at the meeting.
Exhibit No. Description The cover page from this Current Report on Form 8-K, formatted in Inline 104 XBRL (included as Exhibit 101).
--------------------------------------------------------------------------------
© Edgar Online, source